908 Devices Inc. (MASS)

Market Cap	190.78M
Revenue (ttm)	59.63M
Net Income (ttm)	-72.21M
Shares Out	35.33M
EPS (ttm)	-2.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	686,379
Open	5.80
Previous Close	5.66
Day's Range	5.39 - 5.85
52-Week Range	1.81 - 7.48
Beta	0.30
Analysts	Buy
Price Target	5.33 (-1.3%)
Earnings Date	May 13, 2025

About MASS

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 18, 2020
• Employees: 246
• Stock Exchange: NASDAQ
• Ticker Symbol: MASS
• Website: https://908devices.com

Financial Performance

In 2024, 908 Devices's revenue was $59.63 million, an increase of 18.72% compared to the previous year's $50.23 million. Losses were -$72.21 million, 98.4% more than in 2023.

Analyst Forecast

According to 3 analysts, the average rating for MASS stock is "Buy." The 12-month stock price forecast is $5.33, which is a decrease of -1.30% from the latest price.

Price Target

$5.33

(-1.30% downside)

Analyst Consensus: Buy